上海创赛科技有限公司
   
     
联系热线
  • 联系人:刘小姐
  • 电 话:021-59553580
  • 邮箱:order@canspecsci.com
  • 传真:021-59553580-8012
  • 地 址:嘉定区天祝路789弄2号楼901室

[Medlife优选]对乙酰氨基苯酚 APAP

发表时间:2024-03-07

COX抑制剂,Acetaminophen (paracetamol) 是选择性环氧合酶-2 (COX-2) 的抑制剂,IC50 值为 25.8 μM。它是广泛使用的解热和止痛药。

中文名称
对乙酰氨基苯酚 APAP
中文别名
对乙酰氨基酚;醋硝香豆素杂质;醋氨酚 溶液;对乙酰氨基苯酚,CP;对乙酰胺基苯酚;对乙酰氨基苯酚;4'-羟基乙酰苯胺;4 -羟基乙酰苯胺;4-乙酰氨基苯酚;4-乙酰胺基苯酚;N-(4-羟基苯基)乙酰胺;N-乙酰对氨基酚;醋氨酚;对羟基乙酰苯胺;对十二烷基苯酚;对乙酰氨基苯酚,AR;对乙酰氨基酚 EP标准品;对乙酰氨基酚 USP标准品;对乙酰氨基酚 标准品;对乙酰氨基酚-D3;对乙酰氨基酚标准品(JP);对乙酰胺基酚;甘氨酰甘氨酰-L-谷氨酰胺;尼泊金乙酯;扑热息痛;乙酰氨基酚;4-乙酰氨基酚;对醋氨酚;对羟基苯基乙酰胺;分析对照品;退热净;对乙酰氨基酚(4-乙酰氨基酚);萃酚;百服宁;必理通;斯耐普;索密痛;雅司达;醋氨酚,医药级,纯度:>99%
英文名称
Acetaminophen
英文别名
4-Acetamidophenol;acetaminophen;4-(ACETYLAMINO)PHENOL;4'-HYDROXYACETANILIDE;4-HYDROXYACETANILIDE;ACETYL-P-AMINOPHENOL;APAP;N-(4-HYDROXYPHENYL)ACETAMIDE;N-ACETYL-4-AMINOPHENOL;N-ACETYL-P-AMINOPHENOL;P-ACETAMIDOPHENOL;P-ACETAMINOPHENOL;PARACETAMOL;P-HYDROXYACETANILIDE;RARECHEM AB PP 0382;TYLENOL;4'-Hydroxyacetanilide, paracetamol;Acetaminophen NEW;Acetaminophen solution;ACETAMINOPHEN(P);ACETAMINOPHEN(RG);Paracetamol (Acetaminophen);4-Acetamino phenol;Acetaminophenol;Dirox;Dypap;Exdol;Fevor;G 1;Hedex;Korum;NAPAP;Panex;Somedon;4-acetaminophen;扑热息痛;Acetaminofen;Panadol;Datril;Algotropyl;Naprinol;Lonarid;Anelix;Multin;Acenol;Acamol;Liquagesic;Acetagesic;Pyrinazine;Injectapap;Clixodyne;Servigesic;Acetalgin;Abensanil;Gelocatil;Valgesic;Tussapap;Finimal;Valadol;Tralgon;Tabalgin;Lestemp;Alvedon;Apamide;Paracet;Homoolan;Febrolin;Febrilix;Febridol;Dymad
Cas No.
103-90-2
分子式
C8H9NO2
分子量
151.16
包装储存
Powder -20°C 3 years
4°C 2 years

*该产品在溶液状态不稳定,建议您现用现配,即刻使用。

生物活性

Acetaminophen (Paracetamol) is a selective cyclooxygenase-2 (COX-2) inhibitor with an IC50 of 25.8 μM; is a widely used antipyretic and analgesic agent. Acetaminophen is a potent hepatic N-acetyltransferase 2 (NAT2) inhibitor.

性状

Solid

IC50 & Target[1][2]

COX-2

25.8 μM (IC50)

COX-1

113.7 μM (IC50)

体外研究(In Vitro)

体外研究, acetaminophen elicites a 4.4-fold selectivity toward COX-2 inhibition (IC50 113.7 μM for COX-1; IC50 25.8 μM for COX-2). Following oral administration of the drug, maximal ex vivo inhibitions are 56% (COX-1) and 83% (COX-2). Acetaminophen plasma concentrations remaine above the 体外研究 IC50 for COX-2 for at least 5 h postadministration. Ex vivo IC50 values (COX-1: 105.2 μM; COX-2: 26.3 μM) of acetaminophen compared favorably with its 体外研究 IC50 values. In contrast to previous concepts, acetaminophen inhibited COX-2 by more than 80%, i.e., to a degree comparable to nonsteroidal antiinflammatory drugs (NSAIDs) and selective COX-2 inhibitors. However, a >95% COX-1 blockade relevant for suppression of platelet function is not achieved. MTT assay shows that Acetaminophen (APAP) in a dose of 50 mM significantly (p<0.001) reduces cell viability to 61.5±6.65%. Interestingly, the significant (p<0.01) increase in cell viability to 79.7±2.47% is observed in the Acetaminophen/HV110 co-treated cells, compared to Acetaminophen treated cells.

Medlife has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究(In Vivo)

Administering Acetaminophen (250?mg/kg, orally) to the mice causes significant (p<0.001) liver damage and necrosis of cells as evidenced by the elevated serum hepatic enzymes alanine aminotransferase (ALT), aminotransferase (AST), alkaline phosphatase (ALP), and gamma-glutamyl transferase (γGT) compared with normal group. Conversely, effects of pretreatment with different doses of citral (125, 250, and 500?mg/kg) exhibited a significant (p<0.05) decrease in serum activities of ALT (91.79%, 93.07%, and 95.61%, resp.), AST (93.40%, 91.89%, and 96.52%, resp.), ALP (39.29%, 37.07%, and 59.80%, resp.), and γGT (92.83%, 91.59%, and 93.0%, resp.), when compared to the Acetaminophen group. Similar results were found in pretreatment with SLM on the activity of ALT (95.90%), AST (95.03%), ALP (70.52%), and γGT (92.69%).

Medlife has not independently confirmed the accuracy of these methods. They are for reference only.

运输条件

Room temperature or refrigerated transportation.

储存方式
Powder -20°C 3 years
4°C 2 years

*该产品在溶液状态不稳定,建议您现用现配,即刻使用。

ClinicalTrial
参考文献
  • [1]. Hinz, B, et al. Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in man. FASEB J, 2008. 22(2): p. 383-90.  [Information]

    [2]. Miroslav Dini?, et al. Lactobacillus fermentum Postbiotic-induced Autophagy as Potential Approach for Treatment ofAcetaminophen Hepatotoxicity. Front Microbiol. 2017 Apr 6;8:594.  [Information]

    [3]. Uchida NS, et al. Hepatoprotective Effect of Citral on Acetaminophen-Induced Liver Toxicity in Mice. Evid Based Complement Alternat Med. 2017;2017:1796209.  [Information]

    [4]. Rothen JP, et al. Acetaminophen is an inhibitor of hepatic N-acetyltransferase 2 体外研究 and in vivo. Pharmacogenetics. 1998 Dec;8(6):553-9.  [Information]

本文引用:https://www.med-life.cn/product/594.html

Medlife,致力于提供高品质、高性价比小分子化合物的产品。

Medlife小分子化合物大量库存,提供超过2万种的抑制剂、激动剂、拮抗剂等产品,是药物及疾病研究的重要原料供应商。



联系方式
手机:4006087598